Zimislecel (Lantidra™) FDA Approval: Cell Therapy Breakthrough Offers Sustained Insulin Independence for Challenging Type 1 Diabetes Cases
The Landscape of Type 1 Diabetes Treatment Just Changed Dramatically
For individuals battling type 1 diabetes (T1D), particularly those experiencing severe hypoglycemia unawareness and extreme ...
